The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

I.ad

Radiation recall pneumonitis

Publications

Kuriakose J, Sundararaj JJ, Celine T, Isaac B, Mane M, Singh A, Sasidharan B

Osimertinib-induced radiation recall pneumonitis.

BMJ supportive & palliative care 2023 Apr 28;; — 2023 Apr 28

Sanchis-Borja M, Parrot A, Sroussi D, Rivin Del Campo E, Fallet V, Cadranel J

Dramatic Radiation Recall Pneumonitis Induced by Osimertinib after Palliative Thoracic Radiotherapy for Lung Cancer.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2019 Oct;14;e224-e226 — 2019 Oct